SBIR-STTR Award

Bioactive Natural Products From Marine Extremophiles
Award last edited on: 11/28/09

Sponsored Program
SBIR
Awarding Agency
NIH : NCI
Total Award Amount
$97,918
Award Phase
1
Solicitation Topic Code
-----

Principal Investigator
Ramesh C Pandey

Company Information

Xechem International Inc (AKA: Xechem Inc)

379 Thornall Street
Edison, NJ 08837
   (732) 205-0500
   ramesh@xechem.com
   www.xechem.com
Location: Single
Congr. District: 06
County: Middlesx

Phase I

Contract Number: 1R43CA083428-01
Start Date: 00/00/00    Completed: 00/00/00
Phase I year
1999
Phase I Amount
$87,084
Xechem proposes to examine antimicrobial, antifungal, antivira1 and immunomodulatory activities in biological extracts derived from Rutgers University collection of deep-sea hydrothermal vent and sulfide/methane seep organisms in collaboration with marine scientists at Rutgers. This presents a unique opportunity for natural products screening from organisms that live in some of the most extreme environments on this planet, such as high temperatures, great pressures, and strong concentrations of toxic chemicals and radionuclides. Primary biological production in these unusual communities is based on chemosynthesis rather than photosynthesis. In Phase I of the project extracts of 50-l00 marine extremophiles will be examined in l0 Gram positive and Gram negative bacteria, 3 fungal organisms, and 5 viruses representing different virus families. In addition, a screen for an immunomodulating activity will also be performed. Extracts displaying desired activity in these screens will be subjected to bioassay-guided fractionation in Phase II of the Project to isolate and structurally characterize pure biologically active compounds, and initiate in vivo testing of activity. Determining the structures of the active molecules and understanding the mechanisms and pathways used by these organisms to degrade, detoxify, tolerate, or otherwise avoid these compounds may have profound implications for the prevention and treatment of various diseases. PROPOSED COMMERCIAL APPLICATIONS: Rutgers marine biologists have characterized at the molecular level more than two hundred vent and seep species, many new to science. Our collaborative search for antimicrobial, antifungal, antiviral and immunomodu1atory activity in this unique biota may provide many new classes of compounds that have no counterparts in terrestrial plants or animals.

Thesaurus Terms:
antibiotic, biological product, drug discovery /isolation, marine biology antibacterial agent, antifungal agent, chemical structure /function, drug screening /evaluation, immunomodulator, thermophilic organism

Phase II

Contract Number: ----------
Start Date: 00/00/00    Completed: 00/00/00
Phase II year
----
Phase II Amount
$10,834